Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
DANTROLENE 250 MG INTRAVENOUS SUSPENSION (NDC 42367-540-32) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 11, 2026 , from http://ppman.hank.ai/transparency/procedure/42367-540-32/by-state?code_type=NDC
“DANTROLENE 250 MG INTRAVENOUS SUSPENSION (NDC 42367-540-32) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/42367-540-32/by-state?code_type=NDC. Accessed
November 11, 2026 .
“DANTROLENE 250 MG INTRAVENOUS SUSPENSION (NDC 42367-540-32) by State,” HANK Price Transparency ,
accessed November 11, 2026 ,
http://ppman.hank.ai/transparency/procedure/42367-540-32/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
42367-540-32 — Dantrolene 250 Mg Intravenous Suspension
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$9,327
National median
$1,671 – $13,044
IQR (p25 – p75)
14
hospitals filing
5
states
Walking in without insurance?
Cash / self-pay price
Cash median
$14,601
vs. negotiated
+56.5%
Hospitals reporting
50
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 42367-540-32 (NDC), with interquartile range
State Median p25 p75
CA $10,708 $2,920 $13,238
MD $6,484 $3,619 $9,171
IA $1,726 $1,671 $2,157
CT $1,268 $977 $1,646
OH $196 $196 $196